By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chiasma Inc. 

10 Hartom Street, 2nd Floor
P.O. Box 45182
Jerusalem    91450  Israel
Phone: 972-2-571-5885 Fax: 972-2-571-5886


Company News
Israeli Biotech Chiasma Reels in $70 Million Despite Roche (RHHBY) Pullout 2/27/2015 6:22:44 AM
Chiasma Inc. Appoints David Stack As Chairman Of The Board; John A. Scarlett, M.D. Joins Board Of Directors 2/24/2015 6:58:00 AM
Chiasma Inc. Release: Newly Published Phase 3 Study Results Show Positive Outcomes For Octreotide Capsules In People With Acromegaly, A Serious Hormonal Disorder 2/9/2015 12:04:17 PM
Despite Roche (RHHBY) Dropping $595 Million Deal, Chiasma Inc. Bags $33.8 Million 1/2/2015 6:08:15 AM
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/13/2014 5:55:26 AM
Roche (RHHBY) and Chiasma Inc. to Ally on Drug Development for Up to $600 Million 2/19/2013 6:58:50 AM
Chiasma Inc. Closes $38.5 Million Equity Financing 7/23/2012 10:20:16 AM
Chiasma Inc. Release: Data on Investigational Oral Octreolin™ for Acromegaly Demonstrate Growth Hormone Suppression 6/27/2012 9:31:44 AM
Chiasma Inc. to Present at the UBS Global Life Sciences Conference 9/14/2011 10:54:14 AM
Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects 6/6/2011 11:41:29 AM